Actively Recruiting
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Led by Lin Kong, MD · Updated on 2025-12-02
470
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this phase 3 non-inferiority trial is to compare the efficacy and toxicity of proton or photon radiation therapy plus carbon ion radiation therapy for newly diagnosed nasopharyngeal carcinoma. The main question it aims to answer is that if proton radiation therapy plus carbon ion radiation therapy is non-inferior to photon radiation therapy plus carbon ion radiation therapy in terms of therapeutic efficacy. Participants will be randomized to receive either proton radiation therapy (arm 1) or photon radiation therapy (arm 2), in addition to carbon ion radiation therapy (for both arms).
CONDITIONS
Official Title
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willingness to sign the written informed consent.
- Pathologically confirmed Nasopharyngeal carcinoma.
- Patients with any stage of disease except distant metastasis.
- Age: 6 18 and 4 70 years old.
- Eastern Cooperative Oncology Group score: 0-1.
- Adequate laboratory test results.
- Willingness to accept adequate contraception.
You will not qualify if you...
- Presence of distant metastasis.
- Previous radiotherapy to head and neck region.
- Previous surgery (except for biopsy) for the primary lesion or cervical lymph nodes.
- History of malignant tumor within the past 5 years.
- Presence of multiple primary tumors.
- Presence of diseases that may interfere with the evaluation of study endpoints.
- Presence of severe major organ dysfunction.
- Mental illness that may affect the understanding of informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Proton and Heavy Ion Center
Shanghai, Shanghai Municipality, China, 201321
Actively Recruiting
Research Team
L
Lin Kong
CONTACT
J
Jiyi Hu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here